Related Experiment Videos
The economic impact of ALS
1National Organization for Rare Disorders, New Fairfield, CT 06812-8923, USA.
Neurology
|October 1, 1996
Summary
Amyotrophic lateral sclerosis (ALS) presents significant financial challenges for patients and families due to its progressive nature and lack of cure. Educating stakeholders is key to reducing the immense costs associated with ALS care.
Area of Science:
- Neurology
- Healthcare Economics
- Patient Advocacy
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive, degenerative neuromuscular disease with no known cause, treatment, or cure.
- The disease leads to progressive muscle weakness, paralysis, and significant disability.
- Caregiving responsibilities and associated financial burdens predominantly fall on family members.
Purpose of the Study:
- To review the financial implications of ALS diagnosis and disease management.
- To explore financial issues surrounding life support decisions in ALS.
- To discuss cost-effective solutions for managing the economic impact of ALS.
Main Methods:
- Review of financial issues related to ALS diagnosis.
- Analysis of costs associated with managing disease progression.
- Examination of financial burdens related to life support.
Main Results:
- The financial burden for patients and families managing ALS is substantial.
- Costs encompass diagnosis, ongoing care, disease progression management, and life support.
Conclusions:
- Reducing the immense financial burden of ALS requires a multi-faceted approach.
- Education of healthcare providers, patients, families, and payers is crucial for cost reduction.
- Implementing cost-effective solutions can alleviate the economic strain on those affected by ALS.